EUVIMEDEUVIMED entdecken
Crossref

PEMF Potentiates Doxorubicin-induced Late G 2 Arrest in MDA-MB-231 Breast Cancer Cells

Sung-Hun Woo, Byung Chul Jung, Jun-Young Kim, Yong-Heum Lee, Yoon Suk Kim

Anticancer Research · 2024-07 · 44 (7) · 2837-2846

DOI: 10.21873/anticanres.17096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 26.06.2024. Verfasst von Sung-Hun Woo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea. Hauptthemen laut MEDLINE: Doxorubicin, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinBreast NeoplasmsHumansFemaleCell Line, TumorCell SurvivalG2 Phase Cell Cycle CheckpointsElectromagnetic FieldsDNA Topoisomerases, Type IICell ProliferationPaclitaxelFluorouracilPoly-ADP-Ribose Binding Proteinscdc25 PhosphatasesCyclin-Dependent Kinase 2

Stichwörter der Autor:innen

DNA damageMDA-MB-231PEMFPulsed electromagnetic fielddoxorubicinlate G2 arrest

Substanzen

DoxorubicinDNA Topoisomerases, Type IIPaclitaxelTOP2A protein, humanFluorouracilPoly-ADP-Ribose Binding Proteinscdc25 PhosphatasesCyclin-Dependent Kinase 2

Autor:innen und Institutionen

  • Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea.
  • Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, U.S.A.
  • Department of Biomedical Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea.
  • Department of Biomedical Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea koaim@yonsei.ac.kr.
  • Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea; yoonsukkim@yonsei.ac.kr.

Zitieren

APA

Woo, S. H., Jung, B. C., Kim, J. Y., Lee, Y. H., & Kim, Y. S. (2024). PEMF Potentiates Doxorubicin-induced Late G 2 Arrest in MDA-MB-231 Breast Cancer Cells. Anticancer Research, 44(7), 2837-2846. https://doi.org/10.21873/anticanres.17096

Vancouver

Woo SH, Jung BC, Kim JY, Lee YH, Kim YS. PEMF Potentiates Doxorubicin-induced Late G 2 Arrest in MDA-MB-231 Breast Cancer Cells. Anticancer Research. 2024;44(7):2837-2846. doi:10.21873/anticanres.17096

BibTeX
@article{Woo2024,
  author = {Woo, Sung-Hun and Jung, Byung Chul and Kim, Jun-Young and Lee, Yong-Heum and Kim, Yoon Suk},
  title = {PEMF Potentiates Doxorubicin-induced Late G 2 Arrest in MDA-MB-231 Breast Cancer Cells},
  journal = {Anticancer Research},
  year = {2024},
  volume = {44},
  number = {7},
  pages = {2837--2846},
  doi = {10.21873/anticanres.17096}
}
Kostenlos starten →